This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, A R
Right arrow Articles by Stewart, T A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, A R
Right arrow Articles by Stewart, T A

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 December; 12(12): 5541-5547

Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice.

A R Baker, P G Hollingshead, S Pitts-Meek, S Hansen, R Taylor and T A Stewart

Department of Endocrine Research, Genentech Inc., South San Francisco, California 94080.

ABSTRACT

Growth hormone (GH) is an important regulator of postnatal growth, acting on a wide variety of target tissues. Here, we show that local production of GH in osteoblasts is able to stimulate bone growth directly without significant systemic effects. Mice were made transgenic by microinjection of an osteocalcin-human GH (osteocalcin-hGH) gene construct in which approximately 1,800 bp of the rat osteocalcin promoter was fused to the hGH gene. Five lines of transgenic mice, each with measurable amounts of serum hGH (ranging from 1 to 1,000 ng/ml), were analyzed. Northern (RNA) blot hybridization showed that the hGH transcript was detectable only in the bone. Further characterization of hGH mRNA distribution by in situ hybridization revealed that in neonates the most intense signal was found in periosteal osteoblasts, while in adults, trabecular and endosteal osteoblasts were favored. In one transgenic line (992-1), hGH was expressed at a much lower level and had minimal systemic effects; however, the local concentrations of hGH in bone were sufficient to stimulate bone growth in these animals.


Mol Cell Biol. 1992 December; 12(12): 5541-5547




This article has been cited by other articles:

  • Iwaniec, U. T., Wronski, T. J., Amblard, D., Nishimura, Y., van der Meulen, M. C. H., Wade, C. E., Bourgeois, M. A., Damsky, C. D., Globus, R. K. (2005). Effects of disrupted {beta}1-integrin function on the skeletal response to short-term hindlimb unloading in mice. J. Appl. Physiol. 98: 690-696 [Abstract] [Full Text]  
  • Abboud, S. L., Woodruff, K., Liu, C., Shen, V., Ghosh-Choudhury, N. (2002). Rescue of the Osteopetrotic Defect in op/op Mice by Osteoblast-Specific Targeting of Soluble Colony-Stimulating Factor-1. Endocrinology 143: 1942-1949 [Abstract] [Full Text]  
  • Turner, N. D., Knapp, J. R., Byers, F. M., Kopchick, J. J. (2001). Physical and Mechanical Characteristics of Tibias from Transgenic Mice Expressing Mutant Bovine Growth Hormone Genes. Exp. Biol. Med. 226: 133-139 [Abstract] [Full Text]  
  • Hou, Z., Nguyen, Q., Frenkel, B., Nilsson, S. K., Milne, M., van Wijnen, A. J., Stein, J. L., Quesenberry, P., Lian, J. B., Stein, G. S. (1999). Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy. Proc. Natl. Acad. Sci. USA 96: 7294-7299 [Abstract] [Full Text]  
  • Filvaroff, E, Erlebacher, A, Ye, J, Gitelman, S., Lotz, J, Heillman, M, Derynck, R (1999). Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126: 4267-4279 [Abstract]  
  • Erlebacher, A., Filvaroff, E. H., Ye, J.-Q., Derynck, R. (1998). Osteoblastic Responses to TGF-beta during Bone Remodeling. Mol. Biol. Cell 9: 1903-1918 [Abstract] [Full Text]  
  • Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., Slootweg, M. C. (1998). Growth Hormone and Bone. Endocr. Rev. 19: 55-79 [Abstract] [Full Text]  
  • Sims, N. A., White, C. P., Sunn, K. L., Thomas, G. P., Drummond, M. L., Morrison, N. A., Eisman, J. A., Gardiner, E. M. (1997). Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo. Mol. Endocrinol. 11: 1695-1708 [Abstract] [Full Text]  
  • Yu, X.-P., Chandrasekhar, S. (1997). Parathyroid Hormone (PTH 1-34) Regulation of Rat Osteocalcin Gene Transcription. Endocrinology 138: 3085-3092 [Abstract] [Full Text]  
  • Frenkel, B., Capparelli, C., van Auken, M., , D. B., Bryan, J., Stein, J. L., Stein, G. S., Lian, J. B. (1997). Activity of the Osteocalcin Promoter in Skeletal Sites of Transgenic Mice and during Osteoblast Differentiation in Bone Marrow-Derived Stromal Cell Cultures: Effects of Age and Sex. Endocrinology 138: 2109-2116 [Abstract] [Full Text]  
  • Ibaraki-O'Connor, K., Nakata, K., Young, M.F. (1996). Toward Understanding the Function of Amelogenin Using Transgenic Mice. ADR 10: 208-214 [Abstract]